Brief: UroGen Pharma Reports First Quarter 2022 Financial Results
10/05/2022 14:22
May 10 (Reuters) - Urogen Pharma Ltd UR8.F :
* UROGEN PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
RECENT CORPORATE DEVELOPMENTS
* Q1 LOSS PER SHARE $1.25
* Q1 EARNINGS PER SHARE VIEW $-1.33 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw3gKYM3a
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors